Login
CLARIVATE PLC logo

CLARIVATE PLC

clarivate.com

What Do They Do?

Provides research and learning information, software and services to universities, research institutions and governments.

How Do They Make Money?

Customers pay subscription fees at the start of each coverage period for product access or maintenance; patent and trademark renewal services and specific product, data-set or project deliverables are invoiced upon delivery.

revenue
SegmentShareRevenue
A&G
52%
FY2022: 48%
IP
33%
FY2022: 35%
Life Sciences & Healthcare
16%
FY2022: 17%

Who Are Their Customers?

Serves academic and research institutions and libraries, government entities, and businesses including corporations, law firms, and pharmaceutical, biotechnology and medical-device companies.

Do Revenues Turn Into Profits?

Not on paper. It lost $201.1M in FY2025, but brought in more cash than it spent: $365.3M of free cash flow.

Operating income, FY2025
3% of revenue
▲ Turned profitable vs FY2024 (−$275.6M, −11%)
Net income, FY2025
−8% of revenue
▲ +68% (Loss) vs FY2024 (−$636.7M, −25%)
Free cash flow, FY2025
15% of revenue
▲ +2% vs FY2024 ($357.5M, 14%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▼ −9%
vs $530.3M in Q3 FY2025
Net income
▼ −186% (Loss)
vs −$28.3M in Q3 FY2025
A&G share of revenue vs 62.7% in Q3 FY2025
  • Nov 3, 2026 Updated 2026 financial outlook after the segment sale Full-year revenue outlook was $1.965B to $1.985B; fourth-quarter outlook was $490M to $510M.
  • Oct 6, 2026 Sold Life Sciences & Healthcare segment to Altaris Buyer paid $500,000,000 in cash and issued a $75,000,000 note; $25,000,000 in deferred consideration is payable under specified conditions.

Growing. Revenue grew 31% in 4 years, from $1.9B in FY2021 to $2.5B in FY2025, about 7% a year.

A&G product portfolio The older report listed ScholarOne among A&G products; the latest says Clarivate divested ScholarOne and Valipat and began winding down product groups in A&G and Life Sciences & Healthcare.

Revenue over time
A&G IP Life Sciences & Healthcare
$5B$2.5B$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support